当前位置:首页 - 行情中心 - 天山生物(300313) - 财务分析 - 现金流量表

天山生物

(300313)

  

流通市值:25.81亿  总市值:31.36亿
流通股本:1.97亿   总股本:2.40亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金205,467,178.54105,468,939.26217,698,130.2952,670,158.85
  收到的税费返还---27,479.22
  收到其他与经营活动有关的现金2,615,222.13845,721.6343,382,457.1814,027,785.66
  经营活动现金流入小计208,082,400.67106,314,660.89261,080,587.4766,725,423.73
  购买商品、接受劳务支付的现金195,704,482.17109,221,463.58213,662,705.7386,525,018.64
  支付给职工以及为职工支付的现金13,078,534.195,336,192.0718,295,641.5513,861,659.39
  支付的各项税费4,905,572.343,504,156.348,563,950.426,447,489.65
  支付其他与经营活动有关的现金5,597,657.13,266,173.4518,611,885.3310,904,785.69
  经营活动现金流出小计219,286,245.8121,327,985.44259,134,183.03117,738,953.37
  经营活动产生的现金流量净额-11,203,845.13-15,013,324.551,946,404.44-51,013,529.64
二、投资活动产生的现金流量:
  取得投资收益收到的现金--2,868,4201,434,210
  处置固定资产、无形资产和其他长期资产收回的现金净额786,912.22236,260293,650293,650
  处置子公司及其他营业单位收到的现金净额485,124.47---
  投资活动现金流入小计1,272,036.69236,2603,162,0701,727,860
  购建固定资产、无形资产和其他长期资产支付的现金4,567,221.031,932,3666,183,166.612,574,121.03
  支付其他与投资活动有关的现金-1,066,666716,325.67-
  投资活动现金流出小计4,567,221.032,999,0326,899,492.282,574,121.03
  投资活动产生的现金流量净额-3,295,184.34-2,762,772-3,737,422.28-846,261.03
三、筹资活动产生的现金流量:
  吸收投资收到的现金980,000980,0002,450,000-
  其中:子公司吸收少数股东投资收到的现金980,000980,0002,450,000-
  取得借款收到的现金---40,000,000
  收到其他与筹资活动有关的现金20,000,00010,200,00073,380,022-
  筹资活动现金流入小计20,980,00011,180,00075,830,02240,000,000
  偿还债务支付的现金1,500,000-49,700,000200,000
  分配股利、利润或偿付利息支付的现金736,379.68378,329.684,505,107.173,700,671.57
  支付其他与筹资活动有关的现金17,462,4671,400,0004,940,979.25-
  筹资活动现金流出小计19,698,846.681,778,329.6859,146,086.423,900,671.57
  筹资活动产生的现金流量净额1,281,153.329,401,670.3216,683,935.5836,099,328.43
五、现金及现金等价物净增加额-13,217,876.15-8,374,426.2314,892,917.74-15,760,462.24
  加:期初现金及现金等价物余额39,392,937.5339,392,937.5324,500,019.7924,500,019.79
  期末现金及现金等价物余额26,175,061.3831,018,511.339,392,937.538,739,557.55
补充资料:
  净利润5,322,917.95--26,189,029.43-
  资产减值准备1,325,826.06-10,960,621.22-
  固定资产和投资性房地产折旧3,914,837.7-8,826,223.56-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧3,914,837.7-8,826,223.56-
  无形资产摊销1,460,104.72-3,303,529.74-
  长期待摊费用摊销582,572.68-1,250,497.75-
  处置固定资产、无形资产和其他长期资产的损失-131,698.05--81,149.36-
  固定资产报废损失18,674.01-71,428.81-
  财务费用2,909,644.88-9,272,591.39-
  投资损失-3,655,352.22--3,387,136.75-
  递延所得税-150,771.58-356,898.39-
  其中:递延所得税资产减少370,783.44--560,274.49-
    递延所得税负债增加-521,555.02-917,172.88-
  存货的减少-15,903,388.74--18,098,289.63-
  经营性应收项目的减少-13,108,029.67--14,416,607.24-
  经营性应付项目的增加4,440,149.92-28,709,490.4-
  不涉及现金收支的投资和筹资活动金额其他项目--8,089,633.51-
  现金的期末余额26,175,061.38-39,392,937.53-
  减:现金的期初余额39,392,937.53-24,500,019.79-
  现金及现金等价物的净增加额-13,217,876.15-14,892,917.74-
公告日期2026-08-292026-04-252026-04-252025-10-25
审计意见(境内)带强调事项段的无保留意见
TOP↑